1.Retraction: Development of the Mucociliary System in the Murine Eustachian Tube and Middle Ears.
Keehyun PARK ; Ho Ki LEE ; Myung Hyun CHUNG ; Young Myoung KIM ; Jae Young KIM ; David LIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2011;54(1):95-95
No abstract available.
2.Retraction: Development of the Secretory Elements in the Murine Middle Ear and Eustachian Tube.
Keehyun PARK ; Myung Hyun CHUNG ; Young Myoung KIM ; Sung Kyun MOON ; David LIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2011;54(1):93-93
No abstract available.
3.Retraction: Development of the Murine Tubotympanal Cavity.
Keehyun PARK ; Myung Hyun CHUNG ; Byoung Kil HWANG ; Young Myoung KIM ; David J LIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2011;54(1):94-94
No abstract available.
4.Development of the mucociliary system in the murine eustachian tubeand middle ear.
Keehyun PARK ; Ho Ki LEE ; Myung Hyun CHUNG ; Young Myoung KIM ; Jae Young KIM ; David LIM
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(2):262-270
No abstract available.
Ear, Middle*
5.Development of the secretory elements in the murine middle ear and eustachian tube.
Keehyun PARK ; Myung Hyun CHUNG ; Young Myoung KIM ; Sung Kyun MOON ; David LIM
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(6):819-827
No abstract available.
Ear, Middle*
;
Eustachian Tube*
6.Development of the murine tubotympanal cavity.
Keehyun PARK ; Myung Hyun CHUNG ; Byoung Kil HWANG ; Young Myoung KIM ; David J LIM
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(4):583-592
No abstract available.
7.Bird-Egg syndrome diagnosed by ImmunoCap ISAC
Jaeeun CHUNG ; David LEE ; Yoonha HWANG
Allergy, Asthma & Respiratory Disease 2023;11(3):161-163
Adult-onset egg allergy is rare compared to child-onset egg allergy, and the component-resolved diagnosis test is effective in evaluating food allergy. We herein report a 24-year-old woman with late-onset egg-yolk allergy diagnosed as bird-egg syndrome. The prolonged exposure to pet parrots' dander or dropping through the respiratory system caused sensitization to the Gal d 5 component and resulted in a cross-reaction to egg yolk. Since the patient was suspected of the syndrome by her history, the skin prick test, ISAC ImmunoCAP, and serum ImmunoCAP test were performed. By confirming Gal d 5 component by ISAC ImmunoCAP, the patient was diagnosed with the syndrome. In patients with newly adult-onset food allergy, the clinician must identify the environmental conditions which can cause cross-sensitization and perform the causative component test.
8.Evaluation of Efficacy of Polygexamethylene biguanide in Experimental Pseudomonas aeruginosa Keratitis.
Sung Kun CHUNG ; Ja Young LEE ; David G HWANG
Journal of the Korean Ophthalmological Society 1998;39(11):2506-2513
To evaluate the efficacy of polygexamethylene biguanide(PHMB) in Pseudomonas aeruginosa(P. aeruginosa) keratites model, 10microliter of P. aeruginosa bacterial suspension(1x103 colony-forming unit(cfu)/ml) was injected intrastromally into rabbit corneas. Eighteen rabbits(36 eyes) were divided into three treatment groups: balanced salt solution(BSS) group(N=18 eyes). PHMB(0.02%, 200microliter/ml) group(n=9 eyes), tobramycin(14microliter/ml) group(n=9 eyes). Topical antibiotic drops were given hourly from 12 hours after inoculation. A subconjunctival infection was every 24 hours during the first 72 hours. The Severity of keratitis was scored in basked fashion every 8 hours. Corneal buttons were excised and homogenized at the end of the study to determine the viable bacterial counts. In P. aeruginosa keratitis model, tobramycin was statistically more efficacious than PHMB, according the clinical scores at 58 hours(9.9 vs. 15.1, P<0.0001) and log10 cfu(0.54+/-0.21 vs. 4.87+/-1.07. P<0.0001). No differences were found between the PHMB and BSS groups in either clinical scores or bacterial counts. PHMB appears to be ineffective against P. aeruginosa in experimental keratitis model of rabbit.
Bacterial Load
;
Cornea
;
Keratitis*
;
Pseudomonas aeruginosa*
;
Pseudomonas*
;
Tobramycin
9.Inhibition of Basic Fibroblast Growth Factor Induced Rat Corneal Angiogenesis by a Urokinase Plasminogen Activator Receptor Antagonist.
Ja Young LEE ; Sung Kun CHUNG ; David G HWANG
Journal of the Korean Ophthalmological Society 1997;38(4):553-558
During angiogenesis, binding of urokinase plasminogen activator(uPA) and its receptor(uPAR) has been implicated as an important component of the angiogenesis pathway. We have produced a high-affinity competitive antagonist for the uPA receptor consisting of a fusion protein linking the endothelial growth factor(EGF)-like domain of uPA(residues 1-48) to the Fc domain of IgG. To determine whether this recombinant murine uPA1-48-IgG fusion protein could interfere with angiogenesis, we studied the effect of this compound on rat corneal angiogenesisinduced by basic fibroblast growth factor(bFGF). A hydrogel disk containing 250ng of bFGF and 4.2ug of uPA1-48-IgG fusiong protein in seven eyes, 250ug of bFGF and 4.2ug of phosphate-buffered saline(PBS) in another sseven eyes were implanted intrastromally 1.5mm from the superior limbus. At five days post-implantation of bFGF disk, the eyes treated with uPA1-48IgG fusion protein had reduced angiogenesis (mean score=3.1) compared with the PBS-treated controls(mean score=6.1)(P<0.05, Wilcoxon rank sum test). In a rat corneal pocket assay, murine uPA1-48-IgG fusion protein appears to inhibit bFGF-induced angiogenesis. Compounds that block uPAR binding of uPA may have therapeutic potential as anti-angiogenic agents.
Animals
;
Corneal Neovascularization*
;
Fibroblast Growth Factor 2*
;
Fibroblasts
;
Hydrogel
;
Immunoglobulin G
;
Plasminogen Activators*
;
Plasminogen*
;
Rats*
;
Urokinase-Type Plasminogen Activator*
10.Lessons learnt in the management of primary invasive penile cancer in an Australian tertiary referral centre: Clinical outcomes with a minimum 48 months follow-up study.
Eric CHUNG ; Sun YANG ; Louise WHITE ; Simon WOOD ; David NICOL
Korean Journal of Urology 2015;56(2):125-130
PURPOSE: To report on lessons learnt in the management of primary invasive penile cancer in a major tertiary hospital in Australia. MATERIALS AND METHODS: Medical records for all patients who underwent surgery for primary invasive penile cancer between January 2000 and January 2011 were obtained. Patient demographics, clinical status of inguinal node, cancer stage and clinical outcomes were reviewed. All patients were followed up for a minimum of 48 months postoperative unless patient deceased within the first 48 months from the time of penile cancer surgery. RESULTS: Over the 11-year period, a total of 23 cases of invasive penile cancer were identified. Partial penectomy was the most common form of organ preserving surgery and the majority of patients have pT1b disease. Of the 9 patients with clinically palpable inguinal nodes, 7 patients were diagnosed with pN3 disease following inguinal lymphadenectomy. The Kaplan-Meier cancer-specific survival at 72 months showed decreasing survival based on tumour stage (83% in pT1, 79% in pT2, and 64% in pT3 disease) and nodal disease (100% in node negative, 50% in superficial inguinal lymphadenopathy, and 38% in patients with deep inguinal and/or pelvic lymphadenopathy) (p=0.082). The Kaplan-Meier cancer-specific survival revealed statistically significant difference in survival outcome in patients with local recurrence vs. systemic metastasis disease (33% vs. 17%, p=0.008). CONCLUSIONS: The presence of high risk features such as tumour stage, lymph node involvement and distant metastasis carries a significant higher risk of death and tumour recurrence in patients with penile cancer and inguinal lymph node metastasis.
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Squamous Cell/pathology/secondary/*surgery
;
Follow-Up Studies
;
Humans
;
Kaplan-Meier Estimate
;
Lymph Node Excision
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Neoplasm Invasiveness
;
Neoplasm Staging
;
Penile Neoplasms/pathology/*surgery
;
Prognosis
;
Retrospective Studies
;
Risk Factors
;
Treatment Outcome